Effects of Extracorporeal Membrane Oxygenation Circuits on Drug Sequestration: A Review of Ex Vivo Experiments
Authors:
- Stéphane BertinSBStéphane Bertin
- David HaefligerDHDavid Haefliger
- Antoine G. SchneiderASAntoine G. Schneider
- Raphaël GiraudRGRaphaël Giraud
- Maria-Helena PerezMaria-Helena Perez
- Xavier BechtoldXBXavier Bechtold
- Ermindo R. Di PaoloEPErmindo R. Di Paolo
- Laura E. RothuizenLRLaura E. Rothuizen
- Thierry BuclinTBThierry Buclin
- Françoise LivioFLFrançoise Livio
Open Access
- 13 November 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (22) , 8060
Abstract
Background: Extracorporeal membrane oxygenation (ECMO) can affect the disposition of drugs, notably by sequestering them in a circuit. This review aimed to provide a comprehensive summary of existing ex vivo studies investigating the impact of contemporary ECMO circuits on drug sequestration, and to examine the associations between the physicochemical properties of drugs, the features and settings of ECMO devices, and the extent of drug sequestration. Method: A comprehensive search was conducted to identify ex vivo studies that determined drug concentrations in ECMO circuits. Studies that did not allow for the proper assessment of drug loss by degradation were excluded. Drug characteristics and experimental conditions were recorded. Drug sequestration in the circuit was calculated as the difference between the drug loss measured in the ECMO circuit and the drug loss due to spontaneous degradation measured under control conditions. To identify predictors of drug sequestration, a stepwise multiple linear meta-regression was applied by testing the physicochemical properties of drugs and ECMO device features/settings. Results: A total of 40 studies were identified, of which 21 were included in the analysis, covering 41 drugs. The Maquet membrane oxygenator was the most used brand (73%). About half of the circuits were adult and half were pediatric. Our final regression model retained lipophilicity, and to a lesser extent ionization at a physiological pH, as significant predictors of drug sequestration (R2 0.44, relative standard error 23%). Protein binding had no additional effect. Anti-infectives were the most studied class of drugs (n = 28). Antibiotics were overall not significantly sequestered, while lipophilic drugs such as posaconazole, voriconazole, paracetamol, fentanyl, sufentanil, propofol, thiopental, dexmedetomidine and amiodarone were highly sequestered (≥50%). However, this sequestration occurred mainly within the first few hours of the experiments, possibly reflecting a saturation effect. Conclusions: Lipophilic drugs are significantly sequestered in ex vivo ECMO circuits, although this effect may be limited by early saturation.Keywords
This publication has 78 references indexed in Scilit:
- Respiratory Support in COVID-19-Related Respiratory Failure: Lessons Learnt2024
- A physiologically‐based pharmacokinetic modeling approach for dosing amiodarone in children on ECMOCPT: Pharmacometrics & Systems Pharmacology, 2024
- Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) CircuitEuropean Journal of Drug Metabolism and Pharmacokinetics, 2023
- Population pharmacokinetic modeling of GS‐441524, the active metabolite of remdesivir, in Japanese COVID‐19 patients with renal dysfunctionCPT: Pharmacometrics & Systems Pharmacology, 2021
- ECMO for severe ARDS: systematic review and individual patient data meta-analysisIntensive Care Medicine, 2020
- Extracorporeal Life Support for Adults With Respiratory Failure and Related IndicationsJAMA, 2019
- Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children onECMOCPT: Pharmacometrics & Systems Pharmacology, 2018
- Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane OxygenationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Determinants of drug absorption in different ECMO circuitsIntensive Care Medicine, 2010
- Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patientsIntensive Care Medicine, 2003